Recrystallization 2012
DOI: 10.5772/33777
|View full text |Cite
|
Sign up to set email alerts
|

Crystal Forms of Anti-HIV Drugs: Role of Recrystallization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…XRPD also confirmed the presence of the most thermodynamically stable form, form II. 11 Later data collected in this study showed that form I, on the other hand, had a crystallisation exotherm at 139.1 °C (Fig. S1 in the ESI †) and melting endotherm at 178.8 °C with TGA data showing approximately 2% mass loss (Fig.…”
Section: Key Workflow Tasksmentioning
confidence: 65%
See 1 more Smart Citation
“…XRPD also confirmed the presence of the most thermodynamically stable form, form II. 11 Later data collected in this study showed that form I, on the other hand, had a crystallisation exotherm at 139.1 °C (Fig. S1 in the ESI †) and melting endotherm at 178.8 °C with TGA data showing approximately 2% mass loss (Fig.…”
Section: Key Workflow Tasksmentioning
confidence: 65%
“…9 Lamivudine has been shown to produce three crystalline forms, form I, which is a 0.2 hydrate that exhibits needle geometry, and two anhydrous forms, form II, and III which typically adopt bipyramidal 10 and needle morphologies, respectively. 11 Existing patents state that form I and form II are preferred in solid oral dosing. 12 Therefore, the objective of the crystallisation is the purification and management of physical attributes to ease downstream processing.…”
Section: Introductionmentioning
confidence: 99%
“…Solid dispersion technology has been applied to develop formulations with a high drug loading (e.g. Zidovudine Tablets USP 300 mg per tablet) or containing drugs with a high tendency to crystallize 10 . However, the aim of this study was to improve the AZT permeation rate using Pluronic P-407 as an inhibitor of ABC transporters and PLDLA 30/70 to decrease the solubility of zidovudine and to prevent the re-crystallization with a crystal lattice different.…”
Section: Introductionmentioning
confidence: 99%